UK Prime Minister Meets the Team Behind the UK’s Forthcoming Vaccines Manufacturing and Innovation Centre

Healthcare | Latest News | Manufacturing | South East
Prime-Minister-Boris-Johnson-Meets-VMIC-Scientists.

UK Prime Minister Boris Johnson today visited the construction site of the rapidly developing UK’s Vaccines Manufacturing and Innovation Centre (VMIC) at Harwell Science and Innovation Campus.

VMIC, a not-for-profit organisation will provide the UK’s first strategic vaccine development and advanced manufacturing capability that will accelerate vaccines development in the UK and also provide national emergency response for future pandemics.

The Prime Minister met with teams working at the forefront of the national response to COVID-19 – ranging from scientists and engineers advising on scaling up manufacturing of viable COVID-19 vaccines and establishing a rapid deployment centre, known as ‘Virtual VMIC’ to increase supply of the Oxford/AZ vaccine, which is currently in clinical trials to ensure its safety and effectiveness.

Prime Minister Boris Johnson, comments: “Brilliant scientists in Oxfordshire and around the UK are driving global efforts to develop a safe vaccine that works to defeat coronavirus. If one proves successful, we need to be ready to distribute it to the British people as soon as possible.

“That is why construction of the Vaccine Manufacturing and Innovation Centre at Harwell, backed by £158million from the Government, is fully underway in Oxfordshire. When open, VMIC will be able to manufacture enough vaccine doses for the whole UK population in as little as six months, which would transform how we beat this virus and prepare for future pandemics.”

Dr Matthew Duchars, CEO of The Vaccines Manufacturing and Innovation Centre said: “Once complete, the centre will be equipped to provide future pandemic response for the whole of the UK.

“We look forward to being able to deliver on this as part of our day to day work, for the benefit of the UK and overseas.”

VMIC was established by the University of Oxford, Imperial College and London School of Hygiene and Tropical Medicine with support from industrial partners, MSD, Johnson and Johnson and Cytiva, formerly known as GE Healthcare.

The Centre’s initial funding came from a £65 million grant from UK Research and Innovation, as part of the UK Government’s Industrial Strategy Challenge Fund, with a further £93 million in 2020 to expand the facility’s capabilities and fast track the build.

Did you enjoy reading this content?  To get more great content like this subscribe to our magazine

Reader's Comments

Comments related to the current article

Leave a comment

Your email address will not be published. Required fields are marked *